3D-Printed Device Detects Biomarkers of Preterm Birth
May 23, 2019 | ACSEstimated reading time: 1 minute

Preterm birth (PTB) — defined as birth before the 37th week of gestation — is the leading complication of pregnancy. If doctors had a simple, accurate and inexpensive way to identify women at risk for the condition, they could develop better prevention strategies. Now researchers have created a 3D-printed microchip electrophoresis device that can sensitively detect three serum biomarkers of PTB.
According to the World Health Organization, PTB affects about 1 in 10 pregnancies worldwide. Preterm infants can suffer complications such as neurological, respiratory and cardiac problems and, in some cases, even death. Scientists have previously identified biomarker peptides and proteins in maternal serum that can fairly accurately predict PTB at 28 weeks of gestation. However, existing methods for detecting the biomarkers are laborious or not very sensitive. In prior research, Adam Woolley and colleagues used a 2D microfluidic device to separate PTB biomarkers by electrophoresis. But making these devices was slow, error-prone and costly. The process also required a cleanroom, caustic chemicals and highly trained personnel. Therefore, Woolley’s team wanted to develop a 3D-printed microchip device, which would be much simpler, faster and cheaper to make, for separating and detecting fluorescently labeled PTB biomarkers.
The researchers printed their device onto a glass slide using a 3D printer with a custom resin as the ink. To achieve the best separation of three peptide biomarkers by electrophoresis, they optimized the device design, as well as parameters such as applied voltages and buffer identity and composition. The 3D-printed microchip could detect the three PTB biomarkers in the picomolar to low nanomolar range, similar to their 2D microfluidic device. The researchers note that although these detection limits are still higher than the PTB risk levels for the biomarkers, they could increase the sensitivity by adding a component to the device that concentrates the peptides.
Testimonial
"In a year when every marketing dollar mattered, I chose to keep I-Connect007 in our 2025 plan. Their commitment to high-quality, insightful content aligns with Koh Young’s values and helps readers navigate a changing industry. "
Brent Fischthal - Koh YoungSuggested Items
Cicor Posts Strong Order Intake in a Continued Challenging Environment
10/15/2025 | CicorThe Cicor Group continued its growth path during the third quarter of 2025. Quarterly sales increased by 33% to CHF 160.1 million (YTD: CHF 440.8 million, an increase of 25.4%).
Ibiden Opens Ono Plant to Expand AI Server IC Substrate Production Capacity
10/14/2025 | IBIDENIBIDEN Co., Ltd. announces that it held the opening ceremony for its Ono Plant on October 10, 2025 in Ono Town, Ibi District, Gifu Prefecture. Construction work and preparations for mass production at the plant had been underway.
Würth Elektronik Participates in EU Initiative PROACTIF for Cutting-edge Drone and Robotics Solutions
10/14/2025 | Wurth ElektronikWürth Elektronik is a partner in the visionary EU project PROACTIF, funded under the Chips Joint Undertaking (Chips JU). The international consortium of 42 partners from 13 countries aims to strengthen Europe’s technological sovereignty i
Is Glass Finally Coming of Age?
10/13/2025 | Nolan Johnson, I-Connect007Substrates, by definition, form the base of all electronic devices. Whether discussing silicon wafers for semiconductors, glass-and-epoxy materials in printed circuits, or the base of choice for interposers, all these materials function as substrates. While other substrates have come and gone, silicon and FR-4 have remained the de facto standards for the industry.
Zhen Ding Holding Posts September 2025 Monthly Revenue Report
10/10/2025 | Zhen Ding TechnologyZhen Ding Technology Holding Limited, a global leading PCB manufacturer, reported September 2025 revenue of NT$19,362 million, up 32.15% MoM and up 0.13% YoY, marking the second-highest level for the same period in company history.